Related Experiment Video
Updated: Apr 25, 2026

Analysis of Combinatorial miRNA Treatments to Regulate Cell Cycle and Angiogenesis
Published on: March 30, 2019
A Comprehensive Review of Dysregulated miRNAs Involved in Cervical Cancer
Garima Sharma1, Pradeep Dua2, Subhash Mohan Agarwal1
1Bioinformatics Division, Institute of Cytology and Preventive Oncology, Noida-201301, India.
Abstract:
MicroRNAs(miRNAs) have become the center of interest in oncology. In recent years, various studies have demonstrated that miRNAs regulate gene expression by influencing important regulatory genes and thus are responsible for causing cervical cancer. Cervical cancer being the third most diagnosed cancer among the females worldwide, is the fourth leading cause of cancer related mortality. Prophylactic human papillomavirus (HPV) vaccines and new HPV screening tests, combined with traditional Pap test screening have greatly reduced cervical cancer. Yet, thousands of women continue to be diagnosed with and die of this preventable disease annually. This has necessitated the scientists to ponder over ways of evolving new methods and chalk out novel treatment protocols/strategies. As miRNA deregulation plays a key role in malignant transformation of cervical cancer along with its targets that can be exploited for both prognostic and therapeutic strategies, we have collected and reviewed the role of miRNA in cervical cancer. A systematic search was performed using PubMed for articles that report aberrant expression of miRNA in cervical cancer. The present review provides comprehensive information for 246 differentially expressed miRNAs gathered from 51 published articles that have been implicated in cervical cancer progression. Of these, more than 40 miRNAs have been reported in the literature in several instances signifying their role in the regulation of cancer. We also identified 40 experimentally validated targets, studied the cause of miRNAs dysregulation along with its mechanism and role in different stages of cervical cancer. We also identified and analysed miRNA clusters and their expression pattern in cervical cancer. This review is expected to further enhance our understanding in this field and serve as a valuable reference resource.
Insights
MicroRNAs (miRNAs) are key regulators in cervical cancer development. This review details 246 differentially expressed miRNAs and their validated targets, offering insights into novel diagnostic and therapeutic strategies for this prevalent cancer.
Area of Science:
- Oncology
- Molecular Biology
- Genetics
Background:
- Cervical cancer is a major global health concern for women.
- While HPV vaccines and screening have reduced incidence, new strategies are needed.
- MicroRNAs (miRNAs) play a critical role in cervical cancer's malignant transformation.
Purpose of the Study:
- To comprehensively review the role of miRNAs in cervical cancer.
- To consolidate information on differentially expressed miRNAs and their targets.
- To provide a reference for understanding miRNA deregulation in cervical cancer progression.
Main Methods:
- Systematic literature search of PubMed for articles on miRNA expression in cervical cancer.
- Compilation and analysis of data from 51 published articles.
- Identification of differentially expressed miRNAs, validated targets, and miRNA clusters.
Main Results:
- Detailed information on 246 differentially expressed miRNAs implicated in cervical cancer progression.
- Identification of over 40 miRNAs frequently reported for their regulatory roles.
- Analysis of 40 experimentally validated targets, causes of miRNA dysregulation, and their mechanisms across cancer stages.
Conclusions:
- miRNA deregulation is central to cervical cancer pathogenesis.
- Identified miRNAs and targets offer potential for prognostic and therapeutic applications.
- This review serves as a valuable resource for advancing cervical cancer research and treatment.

